Literature DB >> 1385160

Intrathecal CP-96,345 blocks reflex facilitation induced in rats by substance P and C-fiber-conditioning stimulation.

X J Xu1, C J Dalsgaard, Z Wiesenfeld-Hallin.   

Abstract

We have examined the effects of intrathecally (i.t.) administered CP-96,345, a non-peptide NK1 receptor ligand, on the spinal nociceptive flexor reflex and on the facilitation of this reflex evoked by i.t. substance P (SP), neurokinin A (NKA) and electrical conditioning stimulation of cutaneous C-afferents. CP-96,345 i.t. at 24 pmol-2.4 nmol had no significant effect on flexor reflex excitability. At the highest dose tested (24 nmol), CP-96,345 caused a brief facilitation of the flexor reflex, which was similar to the effect of the vehicle used at this drug concentration. CP-96,345 did not depress the flexor reflex at any dose. In rats with chronically implanted i.t. catheters, CP-96,345 at 24 nmol caused neither motor impairment nor morphological damage to the spinal cord. Pretreatment with CP-96,345 dose dependently and similarly antagonized facilitation of the flexor reflex induced by 7 pmol i.t. SP or by a 20-s, 1-Hz conditioning stimulus train applied to cutaneous C-fibers in the sural nerve innervation area. The vehicle had no effect. The antagonistic effect of CP-96,345 on the SP- and C-fiber reflex facilitation induced by conditioning stimulation became maximal only 20-30 min after the i.t. injection and lasted 3-4 h at the highest dose. CP-96,345 did not significantly block the facilitatory effect of 7 pmol i.t. NKA on the flexor reflex. These results demonstrate that CP-96,345 is a potent, long-lasting and selective antagonist of SP in rat spinal cord. Furthermore, facilitation of the flexor reflex (central sensitization) induced by conditioning stimulation of cutaneous C-afferents is mediated by NK1 tachykinin receptors, but the NK1 receptor may not be involved in the transmission of the flexor reflex. CP-96,345 is thus useful in experimental studies of the role of SP in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385160     DOI: 10.1016/0014-2999(92)90428-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Imaging drugs with and without clinical analgesic efficacy.

Authors:  Jaymin Upadhyay; Julie Anderson; Adam J Schwarz; Alexandre Coimbra; Richard Baumgartner; G Pendse; Edward George; Lauren Nutile; Diana Wallin; James Bishop; Saujanya Neni; Gary Maier; Smriti Iyengar; Jeffery L Evelhoch; David Bleakman; Richard Hargreaves; Lino Becerra; David Borsook
Journal:  Neuropsychopharmacology       Date:  2011-08-17       Impact factor: 7.853

2.  Involvement of neurokinin receptors in the induction but not the maintenance of mechanical allodynia in rat flexor motoneurones.

Authors:  Q P Ma; C J Woolf
Journal:  J Physiol       Date:  1995-08-01       Impact factor: 5.182

3.  Evidence for the participation of glutamate in reflexes involving afferent, substance P-containing nerve fibres in the rat.

Authors:  I Juránek; F Lembeck
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

4.  Cardiovascular effects of intrathecal administration of agents active at 5-hydroxytryptamine1-receptors in the rat: modulation by substance P and a substance P antagonist.

Authors:  K Gradin; B Persson
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 5.  Central sensitization: a generator of pain hypersensitivity by central neural plasticity.

Authors:  Alban Latremoliere; Clifford J Woolf
Journal:  J Pain       Date:  2009-09       Impact factor: 5.820

6.  Effect of RP 67580, a non-peptide neurokinin1 receptor antagonist, on facilitation of a nociceptive spinal flexion reflex in the rat.

Authors:  J M Laird; R J Hargreaves; R G Hill
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

7.  Antinociceptive activity of the tachykinin NK1 receptor antagonist, CP-99,994, in conscious gerbils.

Authors:  N M Rupniak; J K Webb; A R Williams; E Carlson; S Boyce; R G Hill
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

Review 8.  A new strategy for the treatment of inflammatory pain. Prevention or elimination of central sensitization.

Authors:  C J Woolf
Journal:  Drugs       Date:  1994       Impact factor: 9.546

9.  Prenatal nicotinic exposure upregulates pulmonary C-fiber NK1R expression to prolong pulmonary C-fiber-mediated apneic response.

Authors:  Lei Zhao; Jianguo Zhuang; Na Zang; Yong Lin; Lu-Yuan Lee; Fadi Xu
Journal:  Toxicol Appl Pharmacol       Date:  2015-10-30       Impact factor: 4.460

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.